April 30, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced the appointment of Stephen Goldy to the newly created position of Vice President of U.S. Sales. Mr. Goldy brings over 20 years of experience developing and …